[1]王　沁.杏桔合剂辅助治疗慢性阻塞性肺疾病急性加重期患者疗效分析[J].新乡医学院学报,2016,33(12):1078-1081.[doi:10.7683/xxyxyxb.2016.12.016]
　WANG Qin.Curative effect of apricot orange mixture in the auxiliary treatment of patients with acute exacerbation period of chronic obstructive pulmonary disease[J].Journal of Xinxiang Medical University,2016,33(12):1078-1081.[doi:10.7683/xxyxyxb.2016.12.016]
点击复制

杏桔合剂辅助治疗慢性阻塞性肺疾病急性加重期患者疗效分析
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
33
期数:
2016年12
页码:
1078-1081
栏目:
临床研究
出版日期:
2016-12-05

文章信息/Info

Title:
Curative effect of apricot orange mixture in the auxiliary treatment of patients with acute exacerbation period of chronic obstructive pulmonary disease
作者:
王　沁
（南京市中医院肺病科，江苏　南京　210001）
Author(s):
WANG Qin
（Department of Pulmonary Disease,Nanjing Hospital of Traditional Chinese Medicine，Nanjing 210001,Jiangsu Province，China）
关键词:
慢性阻塞性肺疾病; 杏桔合剂; 肺功能; 呼吸系统
Keywords:
chronic obstructive pulmonary disease; apricot orange mixture; lung function
分类号:
R563
DOI:
10.7683/xxyxyxb.2016.12.016
文献标志码:
A
摘要:
目的　观察杏桔合剂辅助治疗慢性阻塞性肺疾病急性加重期（AECOPD）患者的临床疗效及安全性。方法　将2015年1月至2016年1月收治的AECOPD患者40例分为杏桔合剂组和常规治疗组，每组20例。2组患者均给予AECOPD常规治疗，杏桔合剂组患者加用杏桔合剂治疗，疗程7 d。分析治疗前后临床症状积分判定疗效，比较静脉血白细胞计数（WBC）、中性粒细胞百分比（N）、超敏C-反应蛋白（hs-CRP）、降钙素原（PCT）、动脉血氧分压（PaO2）和动脉血二氧化碳分压（PaCO2）等指标的变化，选择静脉血丙氨酰氨基转移酶（ALT）、天门冬氨酸氨基转移酶（AST）、尿素氮（BUN）、血清肌酐（SCr）评估用药安全性。结果　杏桔合剂组和常规治疗组患者治疗后总有效率分别为90.0%（18/20）、85.0%（17/20），2组患者治疗后总有效率比较差异无统计学意义（P>0.05）。与治疗前比较，治疗后第3、5、7天2组患者主要临床症状（咳嗽、痰量、气喘）积分均显著下降（P<0.01）；与常规治疗组比较，杏桔合剂组患者在治疗中各观察时间点的咳嗽积分均显著下降（P<0.05），但痰量和气喘积分各观察时间点比较差异无统计学意义（P>0.05）。2组患者治疗后WBC、N、hs-CRP、PCT均较治疗前显著下降，且随治疗时间的延长下降越显著（P<0.01）；与常规治疗组比较，杏桔合剂组患者在治疗第3、7天时WBC、N、hs-CRP下降较显著（P<0.05）。2组患者治疗后PaO2均较治疗前显著升高（P<0.05），PaCO2治疗前后比较差异无统计学意义(P>0.05)；2组患者治疗后PaO2、PaCO2比较差异均无统计学意义(P>0.05)；2组患者治疗前后ALT/AST、BUN、SCr以及组间比较差异均无统计学意义(P>0.05)。结论　杏桔合剂虽不能提高AECOPD患者总疗效，但可快速改善咳嗽，治疗中未见明显肝肾毒性，其作用机制可能通过辅助改善炎症起作用。
Abstract:
Objective　To observe the clinical efficacy and safety of apricot orange mixture in the auxiliary treatment of patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD).Methods　Forty patients with AECOPD in Nanjing Hospital of Traditional Chinese Medicine from January 2015 to January 2016 were randomly divided into apricot orange mixture group and conventional treatment group.All patients were given AECOPD routine treatment.In addition,the patents in apricot orange mixture group were given apricot orange mixture treatment for 7 days.Curative effect was analyzed by comparing the clinical curative effect score before and after treatment.The indexes of white blood cell count(WBC),neutrophils percentage(N),hypersensitive C-reactive protein (hs-CRP),procalcitonin (PCT),partial pressure of oxygen (PaO2) and partial pressure of carbon dioxide (PaCO2) were compared.The indexes of alanine aminotransferase （ALT）,aspartate aminotransferase （AST）,urea nitrogen （BUN） and serum creatinine （SCr） were choose for evaluating the clinical safety of treatment.Results　The total effective rate of patients in apricot orange mixture group and conventional treatment group was 90.0% (18/20) and 85.0% (17/20) respectively after treatment;there was no statistic difference of the total effective rate between the two groups (P>0.05).The main clinical symptoms (cough,phlegm,asthma) scores of patients at 3,5,7 days after treatment were significantly lower than before treatment in the two groups (P<0.01).Compared with the conventional treatment group,the cough scores of patients in apricot orange mixture group were decreased at each observation time point (P<0.05).There were no statistic difference of phlegm and asthma scores of patients at each observation time point between the two groups(P>0.05).The WBC,N,hs-CRP and PCT of patients after treatment were significantly lower than before treatment in the two groups (P<0.01),and the difference was more significant with the increase of treatment time(P<0.01).The WBC,N,hs-CRP of patients in apricot orange mixture group was significantly lower than conventional treatment group at 3 and 7 days after treatment (P<0.05).The PaO2 of patients after treatment was significantly higher than before treatment in the two groups(P<0.05).There was no statistic difference of PaCO2 of patients before and after the treatment in the two groups(P>0.05).There was no statistic difference of PaO2 and PaCO2 of patients after treatment between the two groups(P>0.05).There was no statistic difference of ALT/AST,BUN,SCr of patients before and after treatment in the two groups(P>0.05).There was no statistic difference of ALT/AST,BUN,SCr of patients between the two groups(P>0.05).Conclusion　Apricot orange mixture can′t improve the total curative effect of AECOPD patients.But it can rapidly alleviate cough symptom.In addition,there is no obvious liver and kidney toxicity during apricot orange mixture treatment.Apricot orange mixture may play an auxiliary role by regulating the inflammation.

参考文献/References:

［1］　中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南：2013年修订版 ［J］.中华结核和呼吸杂志,2013,36(4):1-10.
［2］　吕佳康.慢性阻塞性肺疾病中药新药临床研究指导原则制定的可行性探讨［J］.中国临床药理学杂志，2013，29（6）：477-480.
［3］　中华中医药学会内科分会肺系病专业委员会.慢性阻塞性肺疾病中医诊疗指南：2011版 ［J］.中医杂志,2012,53(1):80-84.
［4］　杨扶国.杏仁桔梗与提壶揭盖［J］.江西中医药，2014，45（8）：3-4.
［5］　张金艳，何萍，李贻奎.苦杏仁、桔梗及二者配伍止咳、祛痰作用的研究［J］.中国实验方剂学杂志，2010，16（18）：173-175.
［6］　杨小平，张春梅，冯霞，等.苦杏仁苷口服液制剂临床疗效初探［J］.中药材，2006，29（6）：636-637.
［7］　隋文霞，姚琳，马英丽.桔梗药学研究概况［J］.安徽农业科学，2014，42（16）：4976-4977，5026.
［8］　叶祥庆.布地奈德联合福莫特罗治疗对慢性阻塞性肺疾病患者炎症反应及肺功能的影响［J］.新乡医学院学报，2015，32（11）：1012-1014.
［9］　JIA T G,ZHAO J Q,LIU J H.Serum inflammatory factor and cytokines in AECOPD［J］.Asian Pacific J Tropical Med,2014,7 (12):1005-1008.
［10］　CHEN Y W,LEUNG J M,SIN D D.A systematic review of diagnostic biomarkers of COPD exacerbation［J］.PLoS One,2016,11 (7):e0158843.
［11］　张志海，王彩云，杨天鸣，等.陈皮的化学成分及药理作用研究进展［J］.西北药学杂志，2005，20（1）：47-48.
［12］　于辉，李春香，宫凌涛，等.甘草的药理作用概述［J］.现代生物医学进展，2006，6（4）：77-79.

相似文献/References:

[1]史册.慢性阻塞性肺疾病急性发作期的营养支持治疗[J].新乡医学院学报,2001,18(06):444.
[2]袁晓梅,孙 云,袁宇.慢性阻塞性肺疾病肺心病患者血浆内皮素测定的临床价值[J].新乡医学院学报,2002,19(04):273.
[3]郭志强.慢性阻塞性肺疾病60例院内获得性真菌感染与耐药性分析 [J].新乡医学院学报,2006,23(02):000.
[4]程思远.慢性阻塞性肺疾病继发真菌感染65例病原菌分布及耐药性分析[J].新乡医学院学报,2009,26(01):073.
[5]杨华,周志才,奚峰,等.无创正压通气治疗慢性阻塞性肺疾病急性加重期伴Ⅱ型呼吸衰竭[J].新乡医学院学报,2011,28(02):216.
[6]殷波,惠复新,赵寅滢,等.慢性阻塞性肺疾病急性加重期三重酸碱失衡与急性生理学和慢性健康状况评分Ⅲ评分及预后的关系 [J].新乡医学院学报,2011,28(03):346.
[7]刘金花,徐吟亚,付波.低分子肝素钙对慢性阻塞性肺疾病急性加重期患者血栓前状态的影响[J].新乡医学院学报,2012,29(09):680.
[8]王 沁,郭建辉,梁 栋,等.健脾益肺口服液对慢性阻塞性肺疾病“肺脾气虚证”大鼠动脉血气的影响[J].新乡医学院学报,2014,31(11):896.[doi:10.7683/xxyxyxb.2014.11.00]
[9]朱木林１,袁云华１,邓　巍２,等.慢性阻塞性肺疾病合并外周骨骼肌功能障碍患者炎性因子和代谢水平及线粒体功能的变化[J].新乡医学院学报,2015,32(05):412.
[10]李　航,郭伟丽,安　珍,等.PM2.5对慢性阻塞性肺疾病影响研究进展[J].新乡医学院学报,2016,33(3):234.[doi:10.7683/xxyxyxb.2016.03.020]
　LI Hang,GUO Weili,AN Zhen,et al.Research progress on the effect of PM2.5 on chronic obstructive pulmonary disease[J].Journal of Xinxiang Medical University,2016,33(12):234.[doi:10.7683/xxyxyxb.2016.03.020]

更新日期/Last Update: 2016-12-05